Skip to content

Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury

Neuromodulation of Spinal Circuits: Effects on Spasticity, Nociception, and Motor Activation (Phase II)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06214208
Enrollment
36
Registered
2024-01-19
Start date
2024-02-19
Completion date
2026-12-15
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

The goal of this study is to identify the effect of different types of noninvasive spinal stimulation on spasticity (involuntary muscle activity), muscle strength, and pain in people with spinal cord injury. The spinal stimulation consists of electrical stimulation applied through one electrode over the skin of the lower back and two electrodes over the stomach. Testing will include participating in measurements before the intervention, during intervention, and immediately after the intervention. This study requires participants to come into Shepherd Center 4 consecutive days a week for 2-3 hours per day across 2-3 weeks.

Detailed description

Transcutaneous spinal stimulation (TSS) is a noninvasive electrical stimulation that is applied over the skin of the low back and stomach. In prior research studies, TSS has reduced spasticity without the negative side effects of drug therapies. Although research in TSS is growing, the best dosage of TSS remains unknown. The investigators want to further advance the effects of TSS by comparing three different frequencies. Frequency is the number of electrical pulses that are delivered over a period of time. Frequency can affect the activation of nerves and therefore affect the outcome of TSS. Participation in this study includes testing of the participants' spasticity, strength, and pain before and after 30 minutes of TSS.

Interventions

Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Shepherd Center, Atlanta GA
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must agree to allow use of health information. * Participants should be 16 years old or older. * Participants must have had a spinal cord injury (SCI) of any severity (AIS A, B, C, or D) that happened at least 3 months ago. * Objectively measurable spasticity in your legs. * Participants must inform the investigators if there is a change in medications during the study. * Participants must be able to follow instructions. * Participants must be able to communicate if pain or discomfort is experienced.

Exclusion criteria

* People with spinal issues that are getting worse, such as degenerative or progressive vascular disorders. * People neurological problems other than SCI. * People with an injury level is below T12. * People with un-treated or uncontrolled heart problems that the lead investigator believes could be affected by stimulation or affected by an increase in blood pressure. * People with bone or joint problems that would make it hard to follow the study plan. * Women who are pregnant or actively trying to become pregnant. * People with implanted stimulators (like a baclofen pump, spinal stimulator, heart defibrillator, or diaphragmatic pacemaker) * People with infection. * People with skin that is broken or wounds in the area of the body where stimulation is applied. * People who have or had certain types of cancer in the area of the body where stimulation will be applied. * People who have had botulinum toxin or numbing shots in the test leg or spine in the last 6 months * People who have had permanent spasticity treatment in the test leg or spine (like a certain type of surgery). * Other health issues that the lead investigator things could make it unsafe for you to join the study.

Design outcomes

Primary

MeasureTime frameDescription
Pendulum Test15 minutesDuring the pendulum test, the participant will be lying on a therapy mat with the lower leg hanging off the edge of the mat. A member of the study staff will support the participant's extended lower leg and then release the leg allowing it to swing freely. This test will be video recorded and the movement of the knee joint will be measured using software on the computer.

Secondary

MeasureTime frameDescription
Muscle activation20 minutesParticipants will be asked to activate different leg muscles and produce the maximum amount of force possible. Muscle activation will be measured through sensors placed on the muscles and force production will be measured using a dynamometer.
Posterior root muscle reflexes25 minutesPosterior root muscle reflexes will be used to measure spinal reflex excitability. These reflexes will also be used to determine the intensity of stimulation that is applied during the intervention (0.8x soleus reflex threshold). During this test, participants have a single electrode over the skin of the back (T11/12) and two electrodes over the stomach (umbilicus). Brief pulses of stimulation will be applied at gradually increasing intensities while measuring muscle responses in different leg muscles.
Nociception/Pain15 minutesThe investigators will measure nociception using the flexor reflex. The flexor reflex measures muscle responses to an unpleasant stimulus. Electrodes will be placed at the bottom of the foot. First, the investigators will measure muscle responses to a single stimulus (25 mA). Next, the investigators will measure muscle responses to 5 consecutive stimuli (25 mA). The investigators will then ask participants to rate the unpleasant stimulus on a scale of 0-10.
Ankle Clonus Test15 minutesDuring the ankle clonus test, the participant will be seated at the edge of a mat with the lower leg hanging over the mat. A member of the study staff will support the participant's leg above a box and then release the leg allowing the front of the foot to land on the edge of the box. This test will be video recorded and the movement of the ankle joint will be measured using software on the computer.
Modified Penn Spasm Frequency Scale2 minutesThe Modified Penn Spasm Frequency Scale is a self-report questionnaire that asks participants to rate the frequency and severity of spasms during the last hour.
Stimulation Tolerability Questionnaire2 minutesParticipants will be asked to rate how tolerable the spinal stimulation was during the session and to describe specific sensations that contributed to this rating.
Global Rating of Change Scale1 minuteParticipants will be asked to rate how much their change in spasticity affects their daily life.
Quality of Spasticity Questionnaire5 minutesThe Qualities of Spasticity Survey is a self-report questionnaire that asks participants about the physical qualities of their spasticity and how it impacts daily life. Participants will be asked to report experience with spasticity over the past 48 hours.

Countries

United States

Contacts

Primary ContactJaclyn Miller, PT, DPT
jaclyn.miller@shepherd.org404-350-7638
Backup ContactEvan Sandler, PT, DPT
evan.sandler@shepherd.org404-603-4175

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026